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Abstract
ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3), encoding a receptor of neuregulin-1 (NRG1),
has been considered a functional candidate gene for schizophrenia susceptibility. In order to investigate a relation-
ship between ERBB3 gene and schizophrenia in the Chinese population, case-control and family-based studies
were carried out in 470 cases matched by controls, and in 532 family trios. Our results failed to show any evidence of
significant association between the ERBB3 rs2292238 polymorphism and schizophrenia.
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Evidence of association between the NRG1 (Neure-
gulin-1) gene and schizophrenia has been documented (Li
et al., 2006). The association of schizophrenia and sin-
gle-nucleotidepolymorphisms(SNPs)ofERBB4(v-erb-b2
erythroblastic leukemia viral oncogene homolog 4),
enconding one of the receptors for NRG1 has been shown,
thus suggesting that NRG1-ERBB signaling is involved in
the pathogenesis of schizophrenia (Benzel et al, 2007).
ERBB3 is another NRG1 receptor, and its mRNA has been
reportedtobedown-regulatedinbrainsfromschizophrenic
patients (Hakak et al., 2001; Tkachev et al., 2003). These
findings made ERBB3 a functional candidate gene for sus-
ceptibility to schizophrenia. However, studies in samples
fromtheJapanesepopulationdidnotrevealanyassociation
between ERBB3 polymorphisms and schizophrenia (Kana-
zawa et al., 2007; Watanabe et al., 2007).
In order to investigate the relationship between the
ERBB3 gene and schizophrenia in the Chinese population,
we carried out case-control and family-based studies of the
ERBB3 rs2292238 polymorphism, using samples consisting
of 470 cases matched by controls and 532 family trios (com-
posed each one by normal parents and a single affected off-
spring), all of Han Chinese origin. The patients (mean
duration of illness: five years) were interviewed and diag-
nosedaccordingtotheDSM-IV,bytwoindependentpsychi-
atrists. The case sample included 250 patients from northern
and 220 from southern China; 227 (48.3%) were males and
243 (51.7%) females, with an overall mean age of 32.5 years
(sd = 11.0). The controls consisted of 334 subjects from
northern and 136 from southern China; 225 (47.9%) were
males and 245 (52.1%) females, with an overall mean age of
32.6 years (sd = 9.5). The family trios were composed re-
spectively by 170, 191, and 171 nuclear families from
Shanghai, Anhui and Changchun; among the 532 probands,
260 (48.9%) were males and 272 (51.1%) females. A stan-
dardinformedconsentforthegeneticanalysis,reviewedand
approved by the Shanghai Ethical Committee of Human Ge-
netics, was obtained from all subjects.
Genomic DNA was extracted from peripheral whole
blood using a modified phenol-chloroform method (Gao et
al., 2001). Real-time quantitative PCR with allele-specific
amplification was performed through two PCR reactions
for each sample, carried out in a total volume of 5 L con-
taining 10 ng genomic DNA, 2.5 L Taqman® Universal
PCR Master Mix (Applied Biosystems), 0.2 M allele-
specific primer, 0.2 M common primer and 0.2x SYBR®
Green I (Molecular Probes) on an ABI PRISM 7900 Se-
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Short CommunicationquenceDetectionSystem(AppliedBiosystems).Theprim-
ers used were: 5’-CAAAGTGTTGGGTAATTAGAAG
T-3’,5’-AAAGTGTTGGGTAATTAGAAGG-3’, and 5’-
TACCAGTTGGAACACTTAATCGG-3’. Protocols were
as described by Liu et al. (2005).
A Monte Carlo approach (Sham and Curtis, 1995)
was used in the case-control analysis with 100,000 simula-
tions, in order to estimate exact test probability values.
Transmission (TDT) and pedigree (PDT) disequilibrium
tests, and haplotype-based haplotype relative risk (HHRR)
analyses were used in the family-based samples.
We did not find any difference between cases and
controls when genotype or allele frequencies were com-
pared (
2 = 1.188; 2 d.f.; p = 0.552 and 
2 = 1.130; 1 d.f.;
p = 0.288, respectively). The results summarized in
Tables 1 and 2 showed no evidence of significant associa-
tion for rs2292238 using any of the above strategies. Fur-
thermore, no evidence of association was found when the
probandsofthefamilytrioswereaddedtotheaffectedsam-
ple of the case-control study (data not shown). The sample
sizes we could get in this study would have a sufficient sta-
tisticalpowertodetectthepresenceofasignificantassocia-
tion, if present.
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Table 1 - Results of case-control analyses.

2 tests for
HWE
Observed numbers and
frequencies of genotypes
p values, Odds ratios, 95% CI Observed numbers and
frequencies of alleles
p values, Odds
ratios, 95% CI
GG GT TT GG+GT vs. TT GG vs. GT+TT G T
Patients 0.2818
p = 0.515
52
0.110
216
0.461
201
0.429 0.389
0.89
(0.69-1.15)
0.367
0.83
(0.56-1.24)
320
0.341
618
0.659 0.288
0.90
(0.75-1.09) Controls 0.0721
p = 0.788
61
0.130
220
0.469
188
0.401
342
0.365
596
0.635
Table 2 - Results of family-based analyses.
TDT HHRR PDT
T = 220
NT = 237

2 = 0.632
p = 0.426
T = 220
NT = 237

2 = 0.632
p = 0.426
fr = 0.356 
2 = 0.630
p = 0.427
TDT,Transmission disequilibrium test; HHRR, haplotype-based haplotype relative risk; PDT, pedigree disequilibrium test; T, number of transmissions,
NT, number of non-transmissions.